Future directions in regulatory affairs.

Area of Science:

• Regulatory Affairs
• Pharmaceutical Development
• Health Policy

Background:

• The regulatory affairs landscape is influenced by global megatrends, including geopolitical shifts and the green economy.
• Advances in science, digital disruption, and a patient-centric focus are reshaping therapeutic product development.
• The COVID-19 pandemic accelerated changes in scientific collaboration and regulatory authority interactions.

Purpose of the Study:

• To discuss current trends impacting the development of new therapies.
• To analyze how these trends affect the role of regulatory affairs professionals.
• To provide insights for regulatory professionals to navigate future challenges.

Main Methods:

• Literature review of global trends affecting therapeutic product development.
• Analysis of the impact of these trends on regulatory affairs.
• Discussion of challenges and strategies for regulatory professionals.

Main Results:

• Global megatrends necessitate a focus on manufacturing, supply chain security, and environmental impact.
• Scientific and digital advancements, patient centricity, and inter-regulatory collaboration are key drivers of change.
• Regulatory affairs professionals face evolving demands requiring adaptability and foresight.

Conclusions:

• The role of regulatory affairs professionals is expanding beyond traditional compliance.
• Adaptation to emerging trends is crucial for ensuring timely access to innovative therapies.
• Proactive engagement with scientific, digital, and patient-focused advancements is essential for regulatory success.